Skip Ribbon Commands
Skip to main content
Dr Loh Lih Ming

Dr Loh Lih Ming

MBBS, MMed (Int Med), MRCP (UK), FRCP (Edin), FAMS (Endocrinology)

Senior Consultant

Singapore General Hospital

Specialty: Endocrinology, Endocrinology

Clinical Interest: Hypothalamus-Pituitary-Adrenal Disorders, Growth, Pubertal & Reproductive Disorders, Neuroendocrinology

Clinical Appointments

  • Senior Consultant SingHealth Duke-NUS Diabetes Centre
  • Senior Consultant Endocrinology Singapore General HospitalSingapore General Hospital


​Dr Loh’s special interests are in Pituitary & Adrenal Endocrinology and Neuroendocrinology, and she works very closely with the Neurosurgery, Urology and Nuclear Medicine Departments at SGH, and the Cancer Genetics Clinics at NCCS. Part of her training was at the Endocrinology and Diabetes & Metabolism Units at King’s College Hospital, London. She is heavily involved in Teaching, being a past Director of Training & Education of the Department of Endocrinology, former Associate Program Director of Curriculum of the SingHealth Residency Internal Medicine Program, and Program Evaluation Committee Chairman of the SingHealth Endocrinology Senior Residency Program. She was the Scientific Chairman for the 2012 Course in Advanced Endocrinology. She actively reviews for both our local medical as well as overseas medical journals, and was previously recognized for Reviewing with Distinction for the Singapore Medical Journal. She has won numerous service awards including the SGH CEO Service Award 2010 and the Singapore Health Quality Service Superstar Award 2012. She has been the incumbent Chairman of the SGH Volunteer Club since 2010.


  • Core Faculty, Singhealth Endocrinology Senior Residency Program
  • PEC Chairman, Singhealth Endocrinology Senior Residency Program

Professional Appointments and Committee Memberships

  • Chairman, SGH Volunteer Club
  • Member, CSLD Workgroup for Cancer Genetics, NCCS


  • 2012 Singapore Health Quality Service Award Superstar
  • 2010 CEO Service Award

Research Interests


  1. Chew WHW, Courtney E, Lim KH, Li ST, Chen Y, Tan MH, Chung A, Khoo J, Loh A, Soh SY, Iyer P, Loh LM, Ngeow J. Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing. Mol Genet Genomic Med. 2017 Jul 20;5(5):602-607
  2. Kek PC, Ho ET, Loh LM. Phaeochromocytoma presenting with pseudo-intestinal obstruction and lactic acidosis. Singapore Med J. 2015; 56(8): e131-3 
  3. Aw DK, Sinha RA, Tan HC, Loh LM, Salvatore D, Yen PM. Studies of molecular mechanisms associated with increased deiodinase 3 expression in a case of consumptive hypothyroidism.J Clin Endocrinol Metab. 2014; 99(11): 3965-71 
  4. Loh LM. Chapter 3: Clinical Presentation -- Other Neuroendocrine Tumours. Neuroendocrine Tumours. SingHealth Academy, 2013. ISBN 9789810752323
  5. Loh LM, Goh SY. Chapter 5: Hormones in Harmony Pages 66-77. Beautiful Inside Out: The SingHealth Guide to Women's Health. Singapore Health Services/Reader's Digest Asia Pte Ltd, 2011. ISBN 9789810881061
  6. Loh LM, Hum A, Teoh HL, Lim EC. Graves’ disease associated with spasmodic truncal flexion. Parkinsonism Relat Disord 2005; 11(2): 117-9.
  7. Jose M. Ordovas, Loh LM. Chapter 68: Cardiovascular Disease and Nutrition Pages 737-751. Principles of Gender Specific Medicine. Marianne J Legato, editor. Elsevier Academic Press, San Diego, 2004. ISBN 0124409059
  8. Tan EK, Ho SC, Eng P, Loh LM, Koh L, Lum SY, Teoh ML,Yih Y, Khoo D. Restless legs symptoms in thyroid disorders. Parkinsonism Relat Disord 2004; 10(3): 149-51.
  9. Tan CE, Loh LM, Tai ES. Do Singapore patients require lower doses of statins? The SGH Lipid Clinic experience.Singapore Med J 2003; 44(12): 635-8. 
  10. Tai ES, barin Ali A, Zhang Q, Loh LM, Tan CE, Retnam L, El Oakley RM, Lim SK. Hepatic expression of PPAR alpha, a molecular target of fibrates, is regulated during inflammation in a gender-specific manner.FEBS Lett 2003; 546(2-3): 237-40.
  11. Lo YL, Leoh TH, Loh LM, Tan CE. Statin therapy and small fibre neuropathy: a serial electrophysiological study. J Neurol Sci, 2003; 208(1-2): 105-8.
  12. Tai ES, Ordovas JM, Corella D, Deurenberg-Yap M, Chan E, Adiconis X, Chew SK, Loh LM, Tan CE. The TaqIB and -629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey. Clin Genet. 2003 Jan;63(1):19-30.
  13. Tai ES, Loh LM, Sethi SK, Koay ESC, Lim YT, Tan CE. MEDPED comes to Singapore. Atherosclerosis 2001; 154 (1): 252.
  14. Tai ES, Koay ES, Chan E, Seng TJ, Loh LM, Sethi SK, Tan CE. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia. The 1998 Singapore National Health Survey. Clin Chem 2001; 47(3): 438-43.
  15. Tan CE, LS Chew, ES Tai, LF Chio, HS Lim, LM Loh, J Shepherd. Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control. Atherosclerosis 2001; 154(2): 469-74.

Research Trials